It was never willpower. It's biology.
Compounded semaglutide and tirzepatide — the active molecules in modern GLP-1 therapy — prescribed by a licensed provider, titrated to your response, and monitored every 30 days. Medicine that works on the biology, not your discipline. Compounded medications are prepared by a licensed 503A pharmacy, are not FDA-approved finished drug products, and are not reviewed by the FDA for safety or efficacy. Treatment is not guaranteed and depends on provider review of your medical history.
A complete program, not just a vial
- The medication — compounded semaglutide or tirzepatide, prepared by a licensed 503A pharmacy and shipped to your door, prescribed only when clinically appropriate.
- Dosing and titration — your provider sets a starting dose and titrates it to your response over time, not a one-size protocol.
- Monitoring — a provider check-in every 30 days to review tolerance, side effects and progress, and adjust your dose.
- Support — a bilingual care team, refill coordination, and guidance on nutrition and movement alongside the medication.
Two molecules. One provider decision.
Semaglutide is a compounded GLP-1 receptor agonist. It mimics the GLP-1 hormone to slow gastric emptying and signal satiety, helping reduce appetite and food intake. It is typically started low and titrated over weeks, dosed subcutaneously once a week, with tolerance, gastrointestinal side effects and weight trend reviewed every 30 days.
Tirzepatide is a compounded dual GIP/GLP-1 receptor agonist. It acts on both the GIP and GLP-1 pathways to influence appetite, satiety, and how the body manages glucose. It is titrated gradually from a low starting dose, also dosed subcutaneously once a week, with side effects, blood-sugar response and progress reviewed at each monthly check-in.
Eligibility is a clinical decision
- An ideal candidate: an adult seeking medically supervised weight management, able to complete a provider intake and follow-up, looking for a personalized, titrated approach.
- May require labs first: a history of thyroid or pancreatic conditions, or currently taking other metabolic medications — your provider may request bloodwork before prescribing.
- Not the right fit: a personal or family history of medullary thyroid carcinoma or MEN 2, or if you are pregnant, planning pregnancy, or breastfeeding.
A realistic, titrated arc
- Week 1 — onboarding and first dose. Your provider reviews your intake, sets a low starting dose, and your medication ships. The low start minimizes side effects.
- Week 4 — first titration. Your provider reviews tolerance and how you are responding, then adjusts your dose if appropriate.
- Week 12 — finding your effective dose. Most people have settled into a dose their body tolerates well, with appetite changes established.
- Week 24 — maintenance and review. Ongoing monthly check-ins keep your protocol aligned with your progress and goals.
Common questions
What is compounded semaglutide?
Compounded semaglutide is prepared by a licensed compounding pharmacy using semaglutide, the active molecule studied in GLP-1 therapy. It is not an FDA-approved finished drug product and is not the same as, or a substitute for, any brand-name product.
What side effects should I expect?
The most common effects are gastrointestinal — nausea, reduced appetite, or changes in digestion — and tend to ease as your body adjusts. Your provider reviews these at every check-in and adjusts your dose to improve tolerance.
Where does the medication come from, and is compounding regulated?
Your medication is prepared by a licensed 503A compounding pharmacy and shipped directly to your address. Compounding is performed under state and federal pharmacy regulation. Compounded medications are not FDA-approved finished drug products and are not reviewed by the FDA for safety or efficacy.
Is an in-person visit required, and are these controlled substances?
No in-person visit is required — intake, provider review and follow-ups are completed online, though a provider may request bloodwork through a local lab if clinically indicated. Compounded semaglutide and tirzepatide are not controlled substances; they are prescription medications dispensed only after provider review.
Do I need insurance, and can I cancel?
No insurance is required — the program is self-pay with transparent pricing shown before you start and no membership fee. There is no long-term contract, and you can pause or cancel at any time.